Status:
RECRUITING
Efficacy and Safety of RAdiofrequency Versus HAL- RAR DOppler in Hemorrhoidal Pathology
Lead Sponsor:
Elsan
Conditions:
Hemorrhoids
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Haemorrhoids are composed of tissue rich in blood vessels and are present in all individuals inside the anus (internal haemorrhoids) or under the skin of the anus (external haemorrhoids). Haemorrhoida...
Eligibility Criteria
Inclusion
- Male or Female consulting for hemorrhoidal pathology (grade II or III) after failure of medico-instrumental treatments.
- Age ≥ 18 years and \< 75 years
- Mandatory affiliation to a health insurance system.
- Patient having been informed of the study and having given informed consent
Exclusion
- Patients with chronic inflammatory bowel disease
- Patients with suspected gastro-colic pathology
- Haematological diseases
- Anal fistulas
- Patients unable to discontinue anti-vitamin K or oral anticoagulants
- Associated anal fissure
- External haemorrhoidal disease
- Pregnant or breastfeeding women
- Patients under legal protection
Key Trial Info
Start Date :
January 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04896268
Start Date
January 3 2023
End Date
August 1 2025
Last Update
June 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Private hospital Guillaume de Varye
Saint-Doulchard, France, 18230
2
Centre Clinical
Soyaux, France, 16800